|
PPPDE1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.77949999974936E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.997980E-03 |
| Normal-vs-Stage2 |
6.301900E-02 |
| Normal-vs-Stage3 |
6.426800E-04 |
| Normal-vs-Stage4 |
7.777600E-02 |
| Stage1-vs-Stage2 |
7.997200E-01 |
| Stage1-vs-Stage3 |
2.441900E-02 |
| Stage1-vs-Stage4 |
2.682000E-01 |
| Stage2-vs-Stage3 |
1.065800E-01 |
| Stage2-vs-Stage4 |
2.691600E-01 |
| Stage3-vs-Stage4 |
8.824800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62156999999885E-05 |
| Normal-vs-AfricanAmerican |
7.404300E-04 |
| Normal-vs-Asian |
4.071600E-01 |
| Caucasian-vs-AfricanAmerican |
8.148800E-01 |
| Caucasian-vs-Asian |
6.403000E-01 |
| AfricanAmerican-vs-Asian |
5.695400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.72339999999461E-05 |
| Normal-vs-Female |
2.04640000001088E-06 |
| Male-vs-Female |
2.061900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.067700E-02 |
| Normal-vs-Extreme_Weight |
6.324900E-03 |
| Normal-vs-Obese |
5.96779999999519E-05 |
| Normal-vs-Extreme_Obese |
2.597800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.919600E-01 |
| Normal_Weight-vs-Obese |
2.453200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.029000E-01 |
| Extreme_Weight-vs-Obese |
3.831600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.113400E-01 |
| Obese-vs-Extreme_Obese |
5.189500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.191690E-02 |
| Normal-vs-Age(41-60Yrs) |
1.49290000361901E-08 |
| Normal-vs-Age(61-80Yrs) |
9.639100E-03 |
| Normal-vs-Age(81-100Yrs) |
8.814600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.866800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.284300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.490000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.001410E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.200330E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.514200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.29970000007607E-07 |
| Normal-VS-Type2 PRCC |
8.109800E-02 |
| Normal-VS-KIRP CIMP |
3.385000E-03 |
| Normal-VS-Unclassified PRCC |
1.091910E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.417900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.008100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.919400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.393560E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
3.070000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.902770E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.148580E-01 |
| Normal-vs-N1 |
3.605000E-04 |
| Normal-vs-N2 |
9.585800E-02 |
| N0-vs-N1 |
1.655160E-03 |
| N0-vs-N2 |
9.660200E-03 |
| N1-vs-N2 |
7.637200E-01 |
|
|
